Ovoca Bio plc (OVB.L)
GBp 1.6
(3.23%)
GBp 1.6
(3.23%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 1.11 Million | -5.16 Million | -4.37 Million | -2.11 Million | -2.17 Million | -2.83 Million |
| Net Income | -4.7 Million | -5.61 Million | -5.47 Million | -2.37 Million | -1.97 Million | -2.67 Million |
| Depreciation & Amortization | 300 Thousand | 531 Thousand | 84 Thousand | 71 Thousand | 74 Thousand | 30 Thousand |
| Deferred income taxes | - | - | - | -4000.00 | 6000.00 | - |
| Stock-based compensation | - | 4000.00 | 12 Thousand | 9000.00 | 21 Thousand | - |
| Change in working capital | 1.22 Million | -419 Thousand | 1.1 Million | 416 Thousand | 109 Thousand | -202 Thousand |
| Other non-cash items | 4.37 Million | 332 Thousand | -104 Thousand | -231 Thousand | -402 Thousand | 6000.00 |
| Investing Cash Flow | -49 Thousand | 1.5 Million | -67 Thousand | 7.58 Million | 11.13 Million | -2.03 Million |
| Investments in PPE | -49 Thousand | -42 Thousand | -171 Thousand | -425 Thousand | -630 Thousand | - |
| Acquisitions | - | - | - | - | - | -2.47 Million |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | 347 Thousand | - | 7.74 Million | 11.3 Million | - |
| Other Investing Activities | -49 Thousand | 1.2 Million | 104 Thousand | 265 Thousand | 452 Thousand | 444 Thousand |
| Financing Cash Flow | -879 Thousand | 900 Thousand | - | -4.09 Million | -994 Thousand | 983 Thousand |
| Debt repayment | -879 Thousand | -900 Thousand | - | - | -994 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | -4.09 Million | -994 Thousand | 983 Thousand |
| Accounts receivables | 1.1 Million | -899 Thousand | 77 Thousand | 423 Thousand | -109 Thousand | -120 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | 43 Thousand | 51 Thousand | 175 Thousand | -66 Thousand | -23 Thousand | -147 Thousand |
| Other working capital | 76 Thousand | -470 Thousand | 932 Thousand | 482 Thousand | 132 Thousand | -55 Thousand |
| Cash at beginning of period | 3.7 Million | 6.59 Million | 10.74 Million | 10.07 Million | 1.82 Million | 5.54 Million |
| Cash at end of period | 3.33 Million | 3.7 Million | 6.59 Million | 10.8 Million | 10.15 Million | 1.84 Million |
| Capital Expenditure | -49 Thousand | -42 Thousand | -171 Thousand | -425 Thousand | -630 Thousand | - |
| Effect of forex changes on cash | -553 Thousand | -133 Thousand | 291 Thousand | -646 Thousand | 370 Thousand | 184 Thousand |
| Net cash flow / Change in cash | -366 Thousand | -2.89 Million | -4.15 Million | 733 Thousand | 8.33 Million | -3.7 Million |
| Free Cash Flow | 1.06 Million | -5.2 Million | -4.54 Million | -2.53 Million | -2.8 Million | -2.83 Million |
| Breakdown | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 | 2022 FY | 2022 Q4 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -1244.00 | - | -4.7 Million | -1.18 Million | -5.61 Million | 20 Thousand |
| Depreciation & Amortization | - | - | 300 Thousand | 59.5 Thousand | 531 Thousand | 65.5 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | 4000.00 | 4.00 |
| Change in working capital | -16.00 | - | 1.22 Million | 501.5 Thousand | -419 Thousand | -494 Thousand |
| Other non-cash items | -131.00 | - | 4.37 Million | 285.5 Thousand | 332 Thousand | -79 Thousand |
| Investing Cash Flow | - | - | -49 Thousand | 2000.00 | 1.5 Million | 764.5 Thousand |
| Investments in PPE | - | - | -49 Thousand | - | -42 Thousand | 1500.00 |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | 347 Thousand | - |
| Other Investing Activities | - | - | -49 Thousand | 2000.00 | 1.2 Million | 763 Thousand |
| Financing Cash Flow | -3.00 | - | -879 Thousand | -8500.00 | 900 Thousand | 452.5 Thousand |
| Debt repayment | - | - | -879 Thousand | - | -900 Thousand | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -3.00 | - | - | -8500.00 | - | 452.5 Thousand |
| Accounts receivables | -45.00 | - | 1.1 Million | 511.49 Thousand | -899 Thousand | -392 Thousand |
| Accounts payables | - | - | - | - | - | - |
| Inventory | - | - | 43 Thousand | 8500.00 | 51 Thousand | 44.5 Thousand |
| Other working capital | 29.00 | - | - | -18.5 Thousand | -470 Thousand | -146.5 Thousand |
| Cash at beginning of period | 3337.00 | 2800.00 | 3.7 Million | 3.28 Million | 6.59 Million | 3.76 Million |
| Cash at end of period | 2925.00 | 2800.00 | 3.33 Million | 2.4 Million | 3.7 Million | 3.28 Million |
| Capital Expenditure | - | - | -49 Thousand | - | -42 Thousand | 1500.00 |
| Effect of forex changes on cash | 982.00 | - | -553 Thousand | -105.5 Thousand | -133 Thousand | -1.06 Million |
| Net cash flow / Change in cash | -412.00 | - | -366 Thousand | -882.61 Thousand | -2.89 Million | -484.21 Thousand |
| Free Cash Flow | -1391.00 | - | 1.06 Million | -340 Thousand | -5.2 Million | -486 Thousand |
DPL
8411
VRN
GILD
DOLE
AME